Patents
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
05/2002
05/23/2002WO2001074344A3 Small organic molecule regulators of cell proliferation
05/23/2002WO2001072294A3 Method of treating hepatitis delta viral infection
05/23/2002WO2001049651A3 Aminomethyl-phenyl-cyclohexanone derivatives
05/23/2002WO2001047946A9 GFRα1-RET SPECIFIC AGONISTS AND METHODS THEREFOR
05/23/2002WO2001041760A9 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect
05/23/2002WO2000071121A9 Microgranules insoluble in gastric fluid, method for obtaining same and pharmaceutical preparations
05/23/2002WO2000063204A3 Substituted azoles
05/23/2002WO2000054765A8 Method of treating eating disorders
05/23/2002US20020062008 Novel human beta2 integrin alpha subunit
05/23/2002US20020061923 Diacid isoindoleine amide derivative
05/23/2002US20020061919 Process for the preparation of 1,2,3,9-tetrahydro-9-methyl-3-{(2-methyl-1h-imidazol-1-yl)methyl}-4h-carbazol-4-one
05/23/2002US20020061914 Benzothiazole, benzooxazole and benzoimidazole derivatives as sodium or calcium channel modulators
05/23/2002US20020061911 Enantiomers of 6-amino EM-12 and method of use
05/23/2002US20020061910 Optically pure reboxetine or its methanesulfonate salt inhibits reuptake of norepinephrine
05/23/2002US20020061887 For therapy and prophylaxis of cardiovascular diseases such as hypertension, angina pectoris, cardiac insufficiency, thromboses or atherosclerosis
05/23/2002US20020061877 Substituted cyclic amine metalloprotease inhibitors
05/23/2002US20020061853 Caspase inhibtors and uses thereof
05/23/2002US20020061304 Combined treatment with keratinocyte growth factor and epidermal growth factor inhibitor
05/23/2002CA2448729A1 Piperazinyl and piperidyl substituted heterocyclic compounds
05/23/2002CA2429628A1 Methods of treating p38 kinase-associated conditions and pyrrolotriazine compounds useful as kinase inhibitors
05/23/2002CA2429329A1 Bombesin receptor antagonists
05/23/2002CA2429195A1 Immunoglobulin superfamily proteins
05/23/2002CA2429047A1 Treatment of anti-depression drug-induced sexual dysfunction with apomorphine
05/23/2002CA2428837A1 Microspheres of pancreatic enzymes with high stability
05/23/2002CA2428754A1 Corticotropin releasing factor receptor 2 deficient mice and uses thereof
05/23/2002CA2428527A1 (dihydro)isoquinoline derivatives as phosphodiesterase inhibitors
05/23/2002CA2428519A1 Novel uses of combined selective dopamine d2 receptor antagonists and 5-ht1a receptor agonists
05/23/2002CA2427656A1 Crf receptor antagonists and methods relating thereto
05/23/2002CA2427296A1 Amidoalkyl-piperidine and amidoalkyl-piperazine derivatives for treating of nervous systems disorders
05/23/2002CA2426089A1 Bombesin receptor antagonists
05/22/2002EP1207160A1 Process for the preparation of 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1H-imidazol-1-yl)-methyl)-4H-carbazol-4-one
05/22/2002EP1206938A1 Gastrokinetic bicyclic benzamides of 3- or 4-substituted 4-(aminomethyl)- piperdine derivatives
05/22/2002EP1206935A1 Th2 differentiation inhibitors
05/22/2002EP1206934A1 Blockade of sodium channels by phenol derivatives
05/22/2002EP1206930A2 An oral treatment/care agent
05/22/2002EP1206573A1 26 human secreted proteins
05/22/2002EP1206563A1 Genetically altered dendritic cells transduced with adeno-associated virus (aav), methods of producing said cells and uses thereof
05/22/2002EP1206553A2 Isomerase proteins
05/22/2002EP1206543A2 Membrane associated proteins
05/22/2002EP1206541A1 Dendritic enriched secreted lymphocyte activation molecule
05/22/2002EP1206527A1 Treatment of inflammatory or malignant disease using dnazymes
05/22/2002EP1206491A1 Tgf-beta receptor polynucleotides, polypeptides, and antibodies
05/22/2002EP1206485A2 New effectors of dipeptidyl peptidase iv for topical use
05/22/2002EP1206472A1 Oxazole and thiazole derivatives as neurotrophin production/secretion promoting agent
05/22/2002EP1206471A1 Interleukin-5 inhibiting 6-azauracil derivatives
05/22/2002EP1206467A1 N-heterocyclic derivatives as nos inhibitors
05/22/2002EP1206466A1 Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
05/22/2002EP1206444A1 Compounds that inhibit tryptase activity
05/22/2002EP1206283A2 Improved cellular uptake of bioactive agents
05/22/2002EP1206265A1 Src kinase inhibitor compounds
05/22/2002EP1206263A1 Ft-raman spectroscopic measurement of omeprazole isomer ratio in a composition
05/22/2002EP1206262A1 Npy antagonists: spiroisoquinolinone derivatives
05/22/2002EP1206260A1 Src kinase inhibitor compounds
05/22/2002EP1152776B1 Biodegradable, injectable oligomer-polymer composition
05/22/2002EP0894093B1 Soluble tachykinin antagonists, the preparation and use thereof
05/22/2002EP0792110B1 Silicone compositions
05/22/2002EP0685463B1 Indolin-2-one derivative
05/22/2002EP0665754B1 Antimicrobial peptides
05/22/2002EP0583360B1 Compositions for the prevention and/or treatment of pathological processes
05/22/2002CN1350536A 氨基甲酰基四氢吡啶衍生物 Carbamoyl tetrahydropyridine derivative
05/22/2002CN1350530A 酰胺衍生物 Amide derivatives
05/22/2002CN1350462A Lactobacillus strains capable of preventing diarrhoea caused by pathogenic bacteria and rotaviruses
05/22/2002CN1350461A Lactobacillus strain preventing diarrhoea pathogenic bacteria
05/22/2002CN1350460A Lactic acid bacteria strains capable of preventing diarrhoea
05/22/2002CN1350458A Protease inhibitors
05/22/2002CN1350435A A composition containing carvacrol and thymol for use as abactericide
05/22/2002CN1350002A Deformed streptococcus adherence resisting polypeptide mixture
05/22/2002CN1349828A Beautifying health oral liquid containing cell regulating factor and its making process
05/22/2002CN1349826A Lingguo extract capsule and its prepn. method
05/22/2002CN1349825A Compound Chinese medicine prepn. containing Jisongrong and Its prepn process
05/22/2002CN1349824A Production process of healthy soybean oral liquid
05/22/2002CN1349823A Making process of enzyme degrading oral liquid
05/22/2002CN1349807A Colitis treating Chinese medicine prepn
05/22/2002CN1349799A Chinese medicine Hanhui prepn
05/22/2002CN1349798A Blood pressure lowering and heart protecting tablet and its production process
05/22/2002CN1085209C 5,11-dihydrodibenz [b,3][1,4] oxazepine derivatives and drug compoistions contaiing the derivatives
05/22/2002CN1085084C Medicine for treating acute-chronic abdominal troubles and its preparing method
05/22/2002CN1085079C Use of granisetron for the treatment of post-operative hausea and uomitting
05/21/2002US6392045 9-azobicyclo[3.3.1] non-2-ene derivatives as cholinergic ligands at nicotinic ACH receptors
05/21/2002US6392040 Cyclopentene compounds useful as antagonists of the motilin receptor
05/21/2002US6392039 Coupling; salt formation
05/21/2002US6392028 Functional DNA clone for hepatitis C virus (HCV) and uses thereof
05/21/2002US6391917 Analgesic
05/21/2002US6391909 Anandamide inhibitors as analgesic agents
05/21/2002US6391908 Oxime amide indole type sPLA2 inhibitors
05/21/2002US6391893 Anticancer agents
05/21/2002US6391891 Bicyclic compounds as ligands for 5-HT1 receptors
05/21/2002US6391887 3,4-Dihydroquinoline derivatives as nitrogen monoxide synthase (NOS) inhibitors
05/21/2002US6391878 Compounds such as (4,7-dimethylbenzimidazol-5-yl)guanidine; treating nasal congestion, otitis media, asthma, pain, migraine, gastrointestinal disorder, ulcer
05/21/2002US6391616 Oidiodendron strain for the production of terpenoid lactone compounds
05/21/2002US6391588 Nucleotides squences coding preferential amino acid sequences for use in treating bone disorder in mammals
05/21/2002CA2268327C 3-carboxamide derivatives of 5h-pyrrolo[2,1-c][1,4]-benzodiazepines
05/21/2002CA2153254C Cloning of enterokinase and method of use
05/17/2002CA2363147A1 Stable lactase compositions
05/16/2002WO2002038778A1 Differentiation-inducing substances
05/16/2002WO2002038744A2 Proteases
05/16/2002WO2002038730A2 Novel human potassium channel beta subunit
05/16/2002WO2002038607A2 A 'bach' g protein coupled receptor polypeptide and polynucleotide encoding this receptor
05/16/2002WO2002038594A1 Novel therapeutic compositions for treating infection by lawsonia spp
05/16/2002WO2002038575A1 Glycerophosphoinositol derivatives as modulators of cytosolic a2 phospholipase